Clinuvel Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
23 Apr 24 | BuyUS$51,651 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 5,304 | US$10.25 | |
23 Apr 24 | SellUS$560,648 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 56,759 | US$10.30 | |
04 Apr 24 | BuyUS$750,876 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 80,349 | US$10.71 | |
04 Apr 24 | SellUS$1,147,880 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 120,306 | US$9.54 | |
01 Mar 24 | BuyUS$1,795,574 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 200,309 | US$9.25 | |
01 Mar 24 | SellUS$1,851,015 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 203,327 | US$9.34 | |
23 Feb 24 | BuyUS$5,994,852 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 587,087 | US$11.84 | |
22 Feb 24 | SellUS$5,508,158 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 519,035 | US$11.84 | |
19 Sep 23 | BuyUS$19,253 | Philippe Wolgen | Individual | 1,850 | US$10.41 | |
26 Jun 23 | BuyUS$18,133 | Philippe Wolgen | Individual | 1,532 | US$11.84 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,351,163 | 6.69% |
Individual Insiders | 6,812,612 | 13.6% |
Institutions | 10,457,261 | 20.9% |
General Public | 29,482,729 | 58.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,854,042 | US$37.9m | -10.3% | 0.01% | |||
3,425,222 | US$33.7m | 9.64% | no data | |||
2,590,824 | US$25.5m | 0% | no data | |||
1,974,105 | US$19.4m | 15.7% | no data | |||
1,743,118 | US$17.1m | 0% | no data | |||
1,677,780 | US$16.5m | 253% | 0.01% | |||
795,691 | US$7.8m | -17.9% | no data | |||
603,447 | US$5.9m | 0% | no data | |||
526,676 | US$5.2m | 0.7% | no data | |||
459,763 | US$4.5m | -3.86% | no data | |||
440,085 | US$4.3m | 0% | no data | |||
358,254 | US$3.5m | -36.7% | no data | |||
229,600 | US$2.3m | 0% | no data | |||
200,582 | US$2.0m | -14.9% | no data | |||
187,000 | US$1.8m | 0% | no data | |||
179,480 | US$1.8m | 0% | no data | |||
178,588 | US$1.8m | 0% | no data | |||
156,892 | US$1.5m | 0% | no data | |||
156,874 | US$1.5m | 0% | no data | |||
146,000 | US$1.4m | 0% | no data | |||
116,577 | US$1.1m | 0% | no data | |||
85,589 | US$841.2k | 12% | no data | |||
80,000 | US$786.3k | 0% | no data | |||
72,635 | US$713.9k | 0% | no data | |||
61,535 | US$604.8k | -1.76% | no data |